Feedback / Questions
Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe
Keytruda (pembrolizumab) - Merck (MSD)
nanatinostat (VRx-3996) - Viracta Therap
https://www.prnewswire.com/news-releases/viracta-therapeutics-initiates-phase-1b2-trial-in-epstein-barr-virus-positive-ebv-solid-tumors-301393757.html
Oct 6, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next